Browsing Category
Croda
Omega-3 fatty acid-based self-microemulsifying drug delivery system (SMEDDS) of pioglitazone:…
Pioglitazone (PGL) is an effective insulin sensitizer, however, side effects such as accumulation of subcutaneous fat, edema, and weight gain as well as poor oral bioavailability limit its therapeutic potential for oral delivery. Recent studies have shown that combination of both, PGL and fish oil…
Read More...
Read More...
Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in…
Parkinson’s disease (PD) is the second most common progressive neurodegenerative disorder associated with increased oxidative stress, the underlying vital process contributing to cell death. Tanshinone IIA (TAN) is a phytomedicine with a documented activity in treating many CNS disorders,…
Read More...
Read More...
Developing a robust in vitro release method for a polymeric nanoparticle: Challenges and learnings
Nanomedicines have emerged as a promising approach for targeted therapeutic delivery and specifically as a beneficial alternative to conventional cancer therapies as they can deliver higher concentrations of chemotherapeutic agents at the tumour site compared to healthy tissue, thus providing…
Read More...
Read More...
Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine:…
Chronic stable angina pectoris is the primary indication for ranolazine (RZ), an anti-anginal drug. The drug has an anti-ischemic action that is unaffected by either blood pressure or heart rate. Due to the first-pass effect, the drug has a reduced bioavailability of 35 to 50%. The study emphasized…
Read More...
Read More...
Application of Design of Experiment in the Optimization of Apixaban-Loaded Solid Lipid…
Solid lipid nanoparticles (SLnPs) are usually utilized as lipid-based formulations for enhancing oral bioavailability of BCS class IV drugs. Accordingly, the objective of this work was to investigate the effect of formulation and processing variables on the properties of the developed SLnPs for oral…
Read More...
Read More...
Orthogonal Gelations to Synthesize Core–Shell Hydrogels Loaded with Nanoemulsion-Templated Drug…
Hydrophobic active pharmaceutical ingredients (APIs) are ubiquitous in the drug development pipeline, but their poor bioavailability often prevents their translation into drug products. Industrial processes to formulate hydrophobic APIs are expensive, difficult to optimize, and not flexible enough…
Read More...
Read More...
Croda Pharma introduces new bioprocessing solutions to replace banned materials
PRESS RELEASE
10 August 2023
Croda Pharma has introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need for replacing the popular, but now banned, bioprocessing…
Read More...
Read More...
Lipid based formulations as supersaturating oral delivery systems: from current to future industrial…
Lipid-based formulations, in particular supersaturated lipid-based formulations, are important delivery approaches when formulating challenging compounds, as especially low water-soluble compounds profit from delivery in a pre-dissolved state. In this article, the classification of lipid-based…
Read More...
Read More...
Virodex™ TXR-1 and TXR-2: Safe and effective viral inactivation and cell lysis
The REACH* addition of Triton™ X-100 to the candidate list of Substances of Very High Concern (SVHC), and its subsequent ban in Europe, left biopharmaceutical manufacturers seeking viable alternatives to this essential bioprocessing chemical. Explore the Virodex™ range for viral inactivation and…
Read More...
Read More...
Topical delivery systems containing clotrimazole for the management of candidiasis: effect of…
WHO classified Candida albicans as one of the four critical priority fungi for public health worldwide in 2022. Conventional topical formulations commercially available for the treatment of cutaneous candidiasis are associated with low drug bioavailability at the infection site and the lack of a…
Read More...
Read More...